Moderna Inc. said Wednesday that his experimental coronavirus vaccine caused immune responses in people 56 years and older that were comparable to those seen in younger adults in a small study, a promising sign for a vulnerable age group. Older adults have a higher risk of hospitalization and death of …
Read More »
Text size Dreamstime Older adults who participated in Moderna‘s Phase 1 trial of its Covid-19 vaccine responded just as well as younger adults, according to data, the biotech company presented Wednesday morning to a key Centers for Disease Control and Prevention Advisory panel. This is important because Covid-19 is not …
Read More »
Covid-19 is known to be particularly risky for parents. For many minorities, the disease kills them at the prime of their lives. Among people in the U.S. who have died between their mid-40s and mid-70s since the pandemic began, the virus is responsible for about 9% of deaths. For Latino …
Read More »